November 14th marks World Diabetes Day — a day dedicated to informing and raising public awareness about a condition that has become one of the greatest public health challenges of our century.
According to the most recent global statistics, more than 589 million adults worldwide are living with Type 2 Diabetes (T2D) — that is, over 4 in 10 people. At the same time, global healthcare spending for diabetes now exceeds $1 trillion annually.
Type 2 Diabetes (T2D) is closely linked to obesity, sedentary lifestyle, and unhealthy eating habits, and is a major risk factor for cardiovascular disease, hypertension, hypercholesterolemia, nephropathy, and retinopathy. Moreover, individuals with T2D are more likely to experience dementia, depression, and psychosomatic disorders compared to the general population.
The good news is that Type 2 Diabetes can be prevented or significantly delayed. Gradual weight loss, the adoption of a balanced diet, and regular physical activity are the most powerful “medicines” available. Even a 5–10% reduction in body weight can have remarkable effects on blood sugar regulation and overall health.
From a pharmaceutical standpoint, Metformin remains the first-line treatment, while in recent years, GLP-1 receptor agonists, such as Semaglutide and Liraglutide, have demonstrated impressive efficacy in both glucose control and weight reduction. In 2025, the introduction of dual GLP-1 and GIP receptor agonists is expected to deliver even greater results, further advancing both the prevention and management of the disease.
However, it is essential to remember that no medication can achieve its full potential without accompanying lifestyle changes. Proper nutrition, regular exercise, smoking cessation, and consistent medical monitoring form the foundation of a healthy and high-quality life.
World Diabetes Day serves as a reminder that knowledge, prevention, and early diagnosis save lives. Type 2 Diabetes is a disease whose progression we can slow down, control, and manage effectively — provided we understand the importance of prevention, collaboration with healthcare professionals, and adopting a healthy lifestyle.
Maria Tsiogka, MD, PhD, Endocrinologist
Scientific Associate, Euromedica Egkefalos Chalandriou
Euromedica Egkefalos Chalandriou Diagnostic Center features a dedicated Endocrinology Department, offering specialized care and follow-up for patients with thyroid disorders as well as those living with Type 2 Diabetes (T2D). At the same time, all Euromedica Diagnostic Centers conduct specialized preventive screenings, using state-of-the-art equipment and highly trained medical and paramedical staff, ensuring timely and reliable diagnosis and monitoring of the disease.